InvestorsHub Logo
Followers 61
Posts 7526
Boards Moderated 2
Alias Born 02/10/2010

Re: None

Monday, 05/16/2022 9:46:28 AM

Monday, May 16, 2022 9:46:28 AM

Post# of 146210
Well - at least they mention this:

NanoViricides (NNVC), however, noted that its top priority remains to start human clinical trials of its COVID-19 drug candidate NV-CoV-2.

The company expects filing of a clinical trial application for COVID-19 to take place soon, but noted that the timelines are outside its control.



https://seekingalpha.com/news/3839174-nanoviricides-stock-rises-on-starting-drug-screening-program-to-fight-severe-hepatitis-in-kids

NanoViricides stock rises on starting drug screening program to fight severe hepatitis in kids

“The two most powerful warriors are patience and time.”
- Leo Nikolaevich Tolstoy

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News